This disclosure relates to certain N4-hydroxycytidine derivatives, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to the treatment or prophylaxis of human coronavirus 2019-nCoV.
这项披露涉及某些N
4-羟基
胞苷衍
生物、药物组合物以及相关方法。在某些实施方式中,该披露涉及治疗或预防人类冠状病毒2019-nCoV。